Cadence Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-20,313
Closed -$1.02M 433
2019
Q2
$1.02M Sell
20,313
-123
-0.6% -$5.97K 0.1% 276
2019
Q1
$949K Buy
20,436
+81
+0.4% +$4.1K 0.09% 284
2018
Q4
$999K Sell
20,355
-555
-3% -$31.6K 0.1% 274
2018
Q3
$1.3M Buy
+20,910
New +$1.27M 0.07% 356
2015
Q1
Sell
-39,332
Closed -$1.2M 617
2014
Q4
$1.2M Sell
39,332
-5,128
-12% -$160K 0.07% 347
2014
Q3
$1.3M Buy
+44,460
New +$1.36M 0.07% 334

Other funds holding EHC

Cadence Capital Management's EHC Position: Q3 2019 in Review

Cadence Capital Management sold out of Encompass Health (EHC) in Q3 2019, closing a stake of 20,313 shares — an estimated $1.02M sold.

Cadence Capital Management first reported a position in EHC in Q3 2014 and held it in 6 quarters. The position peaked at $1.3M in Q3 2014. 360 funds tracked by Wall St. Rank hold EHC as of Q3 2019.

  • Cadence Capital Management reported no remaining Encompass Health position as of Q3 2019 after selling out during the quarter.
  • Cadence Capital Management sold 20,313 Encompass Health shares in Q3 2019, an estimated $1.02M.
  • Cadence Capital Management first reported a position in Encompass Health in Q3 2014 and held it in 6 quarters.
  • Cadence Capital Management's Encompass Health position peaked at $1.3M in Q3 2014.
  • 360 funds tracked by Wall St. Rank held Encompass Health as of Q3 2019.

Based on Cadence Capital Management's 13F filing for Q3 2019, filed 29 Oct 2019.